Home › Funds › Artia Global Partners LP › MBX
Artia Global Partners LP position in MBX
MBX BIOSCIENCES INC · Health Care
Artia Global Partners LP reported holding 8,300 shares of MBX (MBX BIOSCIENCES INC) in its Q3 2026 13F filing — a position valued at US$487K, representing 0.10% of its reported portfolio and ranking #48 among its reported holdings. Artia Global Partners LP first reported this position in Q3 2026.
Last updated: 2026-11-16 · Source: SEC EDGAR Form 13F-HR
How Artia Global Partners LP's MBX position evolved
Artia Global Partners LP first disclosed a stake in MBX in Q3 2026 at 8,300 shares (US$487K).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2026 | 8.30K | $486.55K | New |
About MBX and 13F data
MBX (MBX BIOSCIENCES INC) is a Health Care company. 62 other funds we track also report a position in MBX — the largest reported positions include Frazier Life Sciences Management, L.P. (US$367.2M), Paradigm Biocapital Advisors LP (US$221.2M), NEA Management Company, LLC (US$199.5M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding MBX
- Frazier Life Sciences Management, L.P. 6.65M sh · $367.19M · Q2 2026
- Paradigm Biocapital Advisors LP 3.77M sh · $221.17M · Q3 2026
- NEA Management Company, LLC 3.61M sh · $199.52M · Q2 2026
- ORBIMED ADVISORS LLC 3.43M sh · $189.27M · Q2 2026
- NVP Associates, LLC 2.14M sh · $125.23M · Q3 2026
- Aaron Wealth Advisors LLC 1.18M sh · $68.92M · Q3 2026
- Kynam Capital Management, LP 934.80K sh · $54.80M · Q3 2026
- EVENTIDE ASSET MANAGEMENT, LLC 873.49K sh · $51.20M · Q3 2026
- Parkman Healthcare Partners LLC 716.54K sh · $42.00M · Q3 2026
- BRAIDWELL LP 710.88K sh · $39.24M · Q2 2026
- TCG Crossover Management, LLC 650.00K sh · $38.10M · Q3 2026
- Deep Track Capital, LP 640.00K sh · $37.52M · Q3 2026
More on Artia Global Partners LP
FAQ
How long has Artia Global Partners LP held MBX?
Artia Global Partners LP has disclosed MBX holdings in 1 of the last 1 reported quarters, going back to Q3 2026.
What is Artia Global Partners LP's current position in MBX?
As of Q3 2026, Artia Global Partners LP holds 8.30K shares of MBX (MBX BIOSCIENCES INC), valued at $486.55K, representing 0.10% of its reported portfolio and ranking #48.
Has Artia Global Partners LP been buying or selling MBX?
In the latest 13F filing (Q3 2026), Artia Global Partners LP newly opened its position in MBX.
Which other funds hold MBX?
Other major institutional holders of MBX include Frazier Life Sciences Management, L.P., Paradigm Biocapital Advisors LP, NEA Management Company, LLC, among 62 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.